Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.8%

199 terminated/withdrawn out of 1560 trials

Success Rate

83.2%

-3.3% vs industry average

Late-Stage Pipeline

9%

136 trials in Phase 3/4

Results Transparency

38%

372 of 985 completed trials have results

Key Signals

229 recruiting372 with results77 terminated122 withdrawn

Enrollment Performance

Analytics

N/A
726(61.7%)
Phase 2
148(12.6%)
Phase 1
121(10.3%)
Phase 3
76(6.5%)
Phase 4
60(5.1%)
Early Phase 1
45(3.8%)
1176Total
N/A(726)
Phase 2(148)
Phase 1(121)
Phase 3(76)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1560)

Showing 20 of 1560 trials
NCT00114894Phase 3Completed

Prevention of Jellyfish Stings

Role: lead

NCT07227779Phase 2Recruiting

B-PaLMZ for TB Meningitis

Role: collaborator

NCT07301125Not ApplicableEnrolling By Invitation

Myofunctional Therapy for Obstructive Sleep Apnea

Role: lead

NCT07430592Phase 2Not Yet Recruiting

This is a Clinical Study to Assess Whether the Combination of SJ733 and Tafenoquine Will be a Safe and Rapidly Acting Anti-malarial for the Radical Cure of P. Vivax Malaria

Role: collaborator

NCT07735195Not ApplicableNot Yet Recruiting

Tyrannosaurus Flex: Finding the "Fair-ly Normal" Grip

Role: lead

NCT05727761Phase 2Recruiting

Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia

Role: lead

NCT06666322Phase 2Recruiting

Platform Trial For Cryptococcal Meningitis (PLATFORM-CM)

Role: collaborator

NCT05931913Not ApplicableActive Not Recruiting

TMS + Exposure Therapy for Pediatric OCD

Role: collaborator

NCT07057206Phase 1Not Yet Recruiting

Simultaneous Engagement of Networks for Alleviating Pain (SENAP)

Role: lead

NCT05236010Not ApplicableRecruiting

Control Network Neuromodulation to Enhance Cognitive Training in Complex Traumatic Brain Injury

Role: collaborator

NCT07263022Phase 3Recruiting

Cognitive Strategies in Early Psychosis 2

Role: lead

NCT06345833Early Phase 1Withdrawn

Topical and Local TXA in Facelifts - A Randomized Controlled Double Blinded Study

Role: lead

NCT07214948Not ApplicableRecruiting

Open, Randomized Feasibility Trial on the Safety and Performance of the INGA Catheter for Labor Induction

Role: collaborator

NCT07228195Phase 4Recruiting

SGLT2i Therapy in Islet Transplantation (SIT)

Role: lead

NCT06194305Phase 2Recruiting

Multimodal Profiling of Response to Pediatric Comprehensive Behavioral Intervention for Tics

Role: lead

NCT06583577Not ApplicableRecruiting

Ostomy Simulation for Patient Education Prior to Urologic Bowel Diversion Surgeries

Role: lead

NCT07069478Not ApplicableRecruiting

Cannabidiol (CBD) and Stress Response: Psychobiological Mechanisms

Role: lead

NCT07432282Not ApplicableNot Yet Recruiting

Evaluation of the INGA Sensor System for Fetal and Uterine Monitoring During Cervical Ripening

Role: collaborator

NCT05896033Not ApplicableRecruiting

Impact of Cigarette and E-cigarette Menthol Regulation on Current Smokers of Menthol Cigarettes

Role: collaborator

NCT05532657Phase 3Active Not Recruiting

ACHIEVE Brain Health Follow-Up Study

Role: collaborator